O
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13G/A10.1 KBOrexigen Therapeutics, Inc.Aug 24, 3:02 PM ET·0000315066-15-002946
- 8-K15.7 KBOrexigen Therapeutics, Inc.Jan 7, 4:22 PM ET·0001193125-14-004180
- 8-K21.1 KBOrexigen Therapeutics, Inc.Jun 1, 4:01 PM ET·0000950130-10-002511
- 8-K130.4 KBOrexigen Therapeutics, Inc.Oct 1, 6:01 AM ET·0001193125-09-201490
- 8-K2.1 MBOrexigen Therapeutics, Inc.Jun 2, 4:00 PM ET·0001193125-09-123353
- 8-K78.4 KBOrexigen Therapeutics, Inc.Apr 1, 5:14 PM ET·0001193125-09-070769
- 8-K20.4 KBOrexigen Therapeutics, Inc.May 19, 3:36 PM ET·0001181431-08-032524
- 8-K159.1 KBOrexigen Therapeutics, Inc.Jan 24, 7:07 AM ET·0000950134-08-001011
- 8-K54.5 KBOrexigen Therapeutics, Inc.Jan 7, 4:04 PM ET·0000936392-08-000015
- S-12.4 MBOrexigen Therapeutics, Inc.Jan 7, 8:08 AM ET·0000936392-08-000012
Insiders
10- BLAIR JAMES C10% Owner
- BOCK LOUIS CDirector
- Booth Mark DChief Commercial Officer
- DOVEY BRIAN HDirector, 10% Owner
- Hagan Joseph PChief Business Officer
- Klassen PrestonSVP, Head Global Development
- LACOB JOSEPHDirector, 10% Owner
- LANDBLOOM RONALD PVP, Medical and Regulatory
- MCKINNEY ANTHONY AChief Operating Officer
- MORE ROBERT J10% Owner
Tickers
No tickers on record
Addresses
business
3344 N. TORREY PINES CT. SUITE 200
LA JOLLA, CA, 92037
mailing
3344 N. TORREY PINES CT. SUITE 200
LA JOLLA, CA, 92037